144 related articles for article (PubMed ID: 15863303)
1. EB1627: a soluble prodrug of the potent anticancer cyanoguanidine CHS828.
Binderup E; Björkling F; Hjarnaa PV; Latini S; Baltzer B; Carlsen M; Binderup L
Bioorg Med Chem Lett; 2005 May; 15(10):2491-4. PubMed ID: 15863303
[TBL] [Abstract][Full Text] [Related]
2. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties.
Engel D; Nudelman A; Tarasenko N; Levovich I; Makarovsky I; Sochotnikov S; Tarasenko I; Rephaeli A
J Med Chem; 2008 Jan; 51(2):314-23. PubMed ID: 18163551
[TBL] [Abstract][Full Text] [Related]
3. In vitro optimization of non-small cell lung cancer activity with troxacitabine, L-1,3-dioxolane-cytidine, prodrugs.
Radi M; Adema AD; Daft JR; Cho JH; Hoebe EK; Alexander LE; Peters GJ; Chu CK
J Med Chem; 2007 May; 50(9):2249-53. PubMed ID: 17419604
[TBL] [Abstract][Full Text] [Related]
4. New Taxol (paclitaxel) prodrugs designed for ADEPT and PMT strategies in cancer chemotherapy.
Alaoui AE; Saha N; Schmidt F; Monneret C; Florent JC
Bioorg Med Chem; 2006 Jul; 14(14):5012-9. PubMed ID: 16554162
[TBL] [Abstract][Full Text] [Related]
5. Water-soluble prodrugs of an Aurora kinase inhibitor.
Oslob JD; Heumann SA; Yu CH; Allen DA; Baskaran S; Bui M; Delarosa E; Fung AD; Hashash A; Hau J; Ivy S; Jacobs JW; Lew W; Maung J; McDowell RS; Ritchie S; Romanowski MJ; Silverman JA; Yang W; Zhong M; Fuchs-Knotts T
Bioorg Med Chem Lett; 2009 Mar; 19(5):1409-12. PubMed ID: 19186057
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and in vivo antitumor evaluation of 2-methoxyestradiol 3-phosphate, 17-phosphate, and 3,17-diphosphate.
Edsall AB; Agoston GE; Treston AM; Plum SM; McClanahan RH; Lu TS; Song W; Cushman M
J Med Chem; 2007 Dec; 50(26):6700-5. PubMed ID: 18052315
[TBL] [Abstract][Full Text] [Related]
7. Antineoplastic agents. 578. Synthesis of stilstatins 1 and 2 and their water-soluble prodrugs.
Pettit GR; Thornhill A; Melody N; Knight JC
J Nat Prod; 2009 Mar; 72(3):380-8. PubMed ID: 19228038
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological activity of N-2,3-dihydroxypropyl-N-4-chlorobutyl nucleoside phosphoramidate prodrugs.
Wu W; Borch RF
Mol Pharm; 2006; 3(4):451-6. PubMed ID: 16889439
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological activity of prodrug inhibitors of the thioredoxin-thioredoxin reductase system.
Wipf P; Lynch SM; Powis G; Birmingham A; Englund EE
Org Biomol Chem; 2005 Nov; 3(21):3880-2. PubMed ID: 16240002
[TBL] [Abstract][Full Text] [Related]
10. Sulfonyl-containing aldophosphamide analogues as novel anticancer prodrugs targeted against cyclophosphamide-resistant tumor cell lines.
Jain M; Fan J; Baturay NZ; Kwon CH
J Med Chem; 2004 Jul; 47(15):3843-52. PubMed ID: 15239662
[TBL] [Abstract][Full Text] [Related]
11. Do prodrugs deliver?
Smith DA
Curr Opin Drug Discov Devel; 2007 Sep; 10(5):550-9. PubMed ID: 17786853
[TBL] [Abstract][Full Text] [Related]
12. Identification of a potent and stable antiproliferative agent by the prodrug formation of a thiolate histone deacetylase inhibitor.
Suzuki T; Hisakawa S; Itoh Y; Maruyama S; Kurotaki M; Nakagawa H; Miyata N
Bioorg Med Chem Lett; 2007 Mar; 17(6):1558-61. PubMed ID: 17257837
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antitumor activity of CBI-bearing ester and carbamate prodrugs of CC-1065 analogue.
Wang Y; Li L; Tian Z; Jiang W; Larrick JW
Bioorg Med Chem; 2006 Dec; 14(23):7854-61. PubMed ID: 16908174
[TBL] [Abstract][Full Text] [Related]
14. Design and development of water-soluble curcumin conjugates as potential anticancer agents.
Safavy A; Raisch KP; Mantena S; Sanford LL; Sham SW; Krishna NR; Bonner JA
J Med Chem; 2007 Nov; 50(24):6284-8. PubMed ID: 17973470
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antitumor activity evaluations of albumin-binding prodrugs of CC-1065 analog.
Wang Y; Jiang J; Jiang X; Cai S; Han H; Li L; Tian Z; Jiang W; Zhang Z; Xiao Y; Wright SC; Larrick JW
Bioorg Med Chem; 2008 Jul; 16(13):6552-9. PubMed ID: 18508273
[TBL] [Abstract][Full Text] [Related]
16. A novel ruthenium(II) arene based intercalator with potent anticancer activity.
Ruiz J; Vicente C; de Haro C; Bautista D
Dalton Trans; 2009 Jul; (26):5071-3. PubMed ID: 19562164
[TBL] [Abstract][Full Text] [Related]
17. Potent and highly selective hypoxia-activated achiral phosphoramidate mustards as anticancer drugs.
Duan JX; Jiao H; Kaizerman J; Stanton T; Evans JW; Lan L; Lorente G; Banica M; Jung D; Wang J; Ma H; Li X; Yang Z; Hoffman RM; Ammons WS; Hart CP; Matteucci M
J Med Chem; 2008 Apr; 51(8):2412-20. PubMed ID: 18257544
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of pochoxime prodrugs as potent HSP90 inhibitors.
Wang C; Barluenga S; Koripelly GK; Fontaine JG; Chen R; Yu JC; Shen X; Chabala JC; Heck JV; Rubenstein A; Winssinger N
Bioorg Med Chem Lett; 2009 Jul; 19(14):3836-40. PubMed ID: 19410458
[TBL] [Abstract][Full Text] [Related]
19. Design of anticancer prodrugs for reductive activation.
Chen Y; Hu L
Med Res Rev; 2009 Jan; 29(1):29-64. PubMed ID: 18688784
[TBL] [Abstract][Full Text] [Related]
20. Identification of KD5170: a novel mercaptoketone-based histone deacetylase inhibitor.
Payne JE; Bonnefous C; Hassig CA; Symons KT; Guo X; Nguyen PM; Annable T; Wash PL; Hoffman TZ; Rao TS; Shiau AK; Malecha JW; Noble SA; Hager JH; Smith ND
Bioorg Med Chem Lett; 2008 Dec; 18(23):6093-6. PubMed ID: 18954983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
